Short Interest Worth Watching: What Next for Corindus Vascular Robotics Incorporated (NYSEMKT:CVRS) Stock After Decrease in Shorted Shares?

November 30, 2016 - By Adrian Mccoy   ·   0 Comments

Short Interest Worth Watching: What Next for Corindus Vascular Robotics Incorporated (NYSEMKT:CVRS) Stock After Decrease in Shorted Shares?

The stock of Corindus Vascular Robotics Incorporated (NYSEMKT:CVRS) registered a decrease of 10.27% in short interest. CVRS’s total short interest was 5.59 million shares in November as published by FINRA. Its down 10.27% from 6.23 million shares, reported previously. With 872,800 shares average volume, it will take short sellers 6 days to cover their CVRS’s short positions. The short interest to Corindus Vascular Robotics Incorporated’s float is 17.63%. About 99,520 shares traded hands. Corindus Vascular Robotics Inc (NYSEMKT:CVRS) has declined 33.64% since April 27, 2016 and is downtrending. It has underperformed by 38.87% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes and sells precision vascular robotic-assisted systems for use in interventional vascular procedures . The company has a market cap of $76.91 million. The Firm operates through the development, marketing and sales of robotic-assisted vascular interventions segment. It currently has negative earnings. The Company’s product, the CorPath 200 System, is a vascular robotic system, which is engaged in stent placement in percutaneous coronary intervention (PCI) procedures.

CVRS Company Profile

Corindus Vascular Robotics, Inc., incorporated on May 4, 2011, designs, makes and sells precision vascular robotic-assisted systems for use in interventional vascular procedures (the CorPath System). The Firm operates through the development, marketing and sales of robotic-assisted vascular interventions segment. The Company’s product, the CorPath 200 System, is a vascular robotic system, which is engaged in stent placement in percutaneous coronary intervention (PCI) procedures. The CorPath System enables the robotic-assisted control of coronary guidewires and balloon/stent devices from the safety of a radiation-protected, ergonomic interventional cockpit. The CorPath System consists of two components: a bedside unit and an interventional cockpit. At the bedside, the CorPath System’s robotic drive and sterile, single-use cassette (CorPath Cassette) translate the physician’s commands into movements and manipulations of the coronary stents and catheters. The CorPath Cassette provides a single-use sterile interface with standard PCI guidewires and devices.

More notable recent Corindus Vascular Robotics Inc (NYSEMKT:CVRS) news were published by: Businesswire.com which released: “Corindus Vascular Robotics to Present at Upcoming Investor Conferences” on November 02, 2016, also Businesswire.com with their article: “Corindus Vascular Robotics Reports Second Quarter 2016 Results” published on August 04, 2016, Businesswire.com published: “Corindus Vascular Robotics Receives FDA Clearance for Next Generation Robotic …” on October 27, 2016. More interesting news about Corindus Vascular Robotics Inc (NYSEMKT:CVRS) were released by: Businesswire.com and their article: “Corindus Vascular Robotics, Inc. Closes Private Placement for $26.6 Million” published on September 12, 2014 as well as Quotes.Wsj.com‘s news article titled: “News Corindus Vascular Robotics Inc.CVRS” with publication date: October 07, 2014.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Adrian Mccoy


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>